Global Core Electronic Medicinal Product Information (ePI)
1.1.0 - trial-use
Global Core Electronic Medicinal Product Information (ePI)
1.1.0 - trial-use
Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "bundle-epi-type3-example-wonderdrug",
"meta" : {
"versionId" : "1.0",
"lastUpdated" : "2023-10-27T10:00:00Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/bundle-epi-type3"
]
},
"language" : "en",
"identifier" : {
"system" : "http://ema.europa.eu/identifier",
"value" : "WONDERDRUG-500MG-BUNDLE-TYPE3"
},
"type" : "document",
"timestamp" : "2023-10-27T10:00:00Z",
"entry" : [
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/Composition/composition-epi-type3-example-wonderdrug",
"resource" : {
"resourceType" : "Composition",
"id" : "composition-epi-type3-example-wonderdrug",
"meta" : {
"versionId" : "1",
"lastUpdated" : "2023-10-27T10:00:00Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/composition-epi-type1"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><a name=\"Composition_composition-epi-type3-example-wonderdrug\"> </a><p>WonderDrug Summary of Product Characteristics</p></div>"
},
"contained" : [
{
"resourceType" : "Binary",
"id" : "binaryImage-t3",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/binary-epi"
]
},
"contentType" : "image/png",
"data" : "iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mNkYAAAAAYAAjCB0C8AAAAASUVORK5CYII="
}
],
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "composition-epi-type3-example-wonderdrug"
}
],
"version" : "1.0",
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000155532",
"display" : "Summary of Product Characteristics"
}
]
},
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"date" : "2023-10-27",
"author" : [
{
🔗 "reference" : "Organization/org-epi-type3-example-pharma"
}
],
"title" : "WonderDrug 500 mg tablets - Summary of Product Characteristics",
"section" : [
{
"id" : "a5529da2-d8b6-416c-907a-2f6486a49264",
"title" : "SUMMARY OF PRODUCT CHARACTERISTICS",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029791",
"display" : "SUMMARY OF PRODUCT CHARACTERISTICS"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\">Summary of Product Characteristics for WonderDrug</div>"
},
"section" : [
{
"id" : "9f516bb9-8648-4564-883d-885d6d3c8964",
"title" : "1. NAME OF THE MEDICINAL PRODUCT",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029792",
"display" : "1. NAME OF THE MEDICINAL PRODUCT"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>WonderDrug 500 mg tablets</p></div>"
}
},
{
"id" : "9859f8c7-0e7c-4b23-a643-16c907e99041",
"title" : "2. QUALITATIVE AND QUANTITATIVE COMPOSITION",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029793",
"display" : "2. QUALITATIVE AND QUANTITATIVE COMPOSITION"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Each tablet contains 500 mg of paracetamol.</p></div>"
},
"section" : [
{
"id" : "163ef829-7ba3-486f-85e7-2a0c8d6e03d9",
"title" : "2.1 General description",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029794",
"display" : "2.1 General description"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>White, round, biconvex tablets.</p></div>"
}
},
{
"id" : "4adc7d65-1c20-4f6b-871a-8f412de5d2a4",
"title" : "2.2 Qualitative and quantitative composition",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029795",
"display" : "2.2 Qualitative and quantitative composition"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Each tablet contains 500 mg paracetamol.</p></div>"
}
},
{
"id" : "58eac29a-da40-491a-a068-09f622fbe455",
"title" : "Excipient(s) with known effect",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029796",
"display" : "Excipient(s) with known effect"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>For the full list of excipients, see section 6.1.</p></div>"
}
}
]
},
{
"id" : "c29ca0cb-6b4b-40b6-9362-804a2d42cd2d",
"title" : "3. PHARMACEUTICAL FORM",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029797",
"display" : "3. PHARMACEUTICAL FORM"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Tablet. White, round, biconvex tablets.</p></div>"
}
},
{
"id" : "c36bb7fe-be38-4acc-ad4b-9dd188752ca8",
"title" : "4. CLINICAL PARTICULARS",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029798",
"display" : "4. CLINICAL PARTICULARS"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Clinical information about WonderDrug.</p></div>"
},
"section" : [
{
"id" : "339c6a45-06ea-48d7-9eef-ca80a6c284d5",
"title" : "4.1 Therapeutic indications",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029799",
"display" : "4.1 Therapeutic indications"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Symptomatic treatment of mild to moderate pain and/or fever.</p></div>"
}
},
{
"id" : "efd69da5-2510-445d-a59d-261632a92cec",
"title" : "4.2 Posology and method of administration",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029800",
"display" : "4.2 Posology and method of administration"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Adults: 1-2 tablets every 4-6 hours. Maximum 8 tablets in 24 hours.</p></div>"
}
},
{
"id" : "477becff-ccc3-4f82-ac9b-d91a8ba4ace3",
"title" : "4.3 Contraindications",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029805",
"display" : "4.3 Contraindications"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Hypersensitivity to paracetamol or any of the excipients.</p></div>"
}
},
{
"id" : "1878af14-22b3-4da4-aea8-0bfad72e101e",
"title" : "4.4 Special warnings and precautions for use",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029806",
"display" : "4.4 Special warnings and precautions for use"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Caution in patients with hepatic or renal impairment.</p></div>"
}
},
{
"id" : "f3f877bf-322c-4823-bccc-d597f34e1168",
"title" : "4.5 Interaction with other medicinal products and other forms of interaction",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029809",
"display" : "4.5 Interaction with other medicinal products and other forms of interaction"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Anticoagulants: Enhanced effect of warfarin with prolonged use.</p></div>"
}
},
{
"id" : "fd945cc2-f076-4f7e-bae0-b1dcd4279854",
"title" : "4.6 Fertility, pregnancy and lactation",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029811",
"display" : "4.6 Fertility, pregnancy and lactation"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Can be used during pregnancy and lactation at recommended doses.</p></div>"
}
},
{
"id" : "2ee553da-6e3d-4033-b351-16b624d57bdf",
"title" : "4.7 Effects on ability to drive and use machines",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029815",
"display" : "4.7 Effects on ability to drive and use machines"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>No known effect.</p></div>"
}
},
{
"id" : "9bfa53f3-3404-459e-97ab-7e090ffc2812",
"title" : "4.8 Undesirable effects",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029816",
"display" : "4.8 Undesirable effects"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris.</p><p><b>Summary of adverse reactions:</b></p><ul><li>Very common (≥1/10): Nausea, headache</li><li>Common (≥1/100 to <1/10): Dizziness, fatigue</li><li>Uncommon (≥1/1,000 to <1/100): Allergic reactions, skin rash</li><li>Rare (≥1/10,000 to <1/1,000): Hepatotoxicity</li></ul><table border=\"1\"><tr><th>System Organ Class</th><th>Frequency</th><th>Adverse Reaction</th></tr><tr><td>Gastrointestinal</td><td>Very common</td><td>Nausea</td></tr><tr><td>Nervous system</td><td>Very common</td><td>Headache</td></tr><tr><td>Skin</td><td>Uncommon</td><td>Rash, pruritus</td></tr></table><p>Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.</p><p><img src=\"data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxMDAiIGhlaWdodD0iMTAwIj48Y2lyY2xlIGN4PSI1MCIgY3k9IjUwIiByPSI0MCIgc3Ryb2tlPSJibGFjayIgc3Ryb2tlLXdpZHRoPSIzIiBmaWxsPSJyZWQiIC8+PC9zdmc+\" alt=\"Sample SVG Image\"/></p></div>"
}
},
{
"id" : "0c762653-f91a-42c9-a5ae-5ec2d46eebf4",
"title" : "4.9 Overdose",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029819",
"display" : "4.9 Overdose"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Symptoms: Hepatic damage. Treatment: N-acetylcysteine.</p></div>"
}
}
]
},
{
"id" : "163e3b46-07f3-428f-9015-563df3345349",
"title" : "5. PHARMACOLOGICAL PROPERTIES",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029821",
"display" : "5. PHARMACOLOGICAL PROPERTIES"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Pharmacological properties of WonderDrug.</p></div>"
},
"section" : [
{
"id" : "1aa4d0d4-2137-4cd8-ac7f-d6f910eebcfb",
"title" : "5.1 Pharmacodynamic properties",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029822",
"display" : "5.1 Pharmacodynamic properties"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Pharmacotherapeutic group: Analgesics, ATC code: N02BE01.</p></div>"
}
},
{
"id" : "1fa3fb24-9319-4a6a-ab27-09e99372c584",
"title" : "5.2 Pharmacokinetic properties",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029827",
"display" : "5.2 Pharmacokinetic properties"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Rapidly absorbed from the GI tract. Peak plasma concentration in 30-60 minutes.</p></div>"
}
},
{
"id" : "1ddebeef-c6c6-4466-ba94-ded89fbfb7ab",
"title" : "5.3 Preclinical safety data",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029834",
"display" : "5.3 Preclinical safety data"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>No additional data of relevance.</p></div>"
}
}
]
},
{
"id" : "3354d395-ff4f-4cf2-9715-79d1572c5bd8",
"title" : "6. PHARMACEUTICAL PARTICULARS",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029836",
"display" : "6. PHARMACEUTICAL PARTICULARS"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Pharmaceutical particulars for WonderDrug.</p></div>"
},
"section" : [
{
"id" : "1810edbd-e273-47ca-ac6d-95da39cbbf65",
"title" : "6.1 List of excipients",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029837",
"display" : "6.1 List of excipients"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Pregelatinised starch, maize starch, magnesium stearate.</p></div>"
}
},
{
"id" : "92f549e6-2502-4a47-a0b2-d15481e5173b",
"title" : "6.2 Incompatibilities",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029838",
"display" : "6.2 Incompatibilities"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Not applicable.</p></div>"
}
},
{
"id" : "29fb1695-4488-4e67-863b-ea8c0ce4d53d",
"title" : "6.3 Shelf life",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029839",
"display" : "6.3 Shelf life"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>3 years.</p></div>"
}
},
{
"id" : "5d7ccb0a-ad90-4497-acbf-80d4f75dce83",
"title" : "6.4 Special precautions for storage",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029840",
"display" : "6.4 Special precautions for storage"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Store below 25°C.</p></div>"
}
},
{
"id" : "c6299d8a-2062-40b4-bac1-d2076f43cdac",
"title" : "6.5 Nature and contents of container",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029841",
"display" : "6.5 Nature and contents of container"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>PVC/Aluminium blisters. Pack sizes: 10, 20, 30 tablets.</p></div>"
}
},
{
"id" : "51d4458e-096d-4980-9d3a-6efd9e72185f",
"title" : "6.6 Special precautions for disposal",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029842",
"display" : "6.6 Special precautions for disposal"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>No special requirements.</p></div>"
}
}
]
},
{
"id" : "547a1ef0-952a-4dc0-8dc8-583445d2c680",
"title" : "7. MARKETING AUTHORISATION HOLDER",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029844",
"display" : "7. MARKETING AUTHORISATION HOLDER"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>WonderPharma Inc., 123 Pharma Way, Prague, Czech Republic</p></div>"
}
},
{
"id" : "a717d6c2-dd85-47c9-9d0a-06185f400226",
"title" : "8. MARKETING AUTHORISATION NUMBER(S)",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029845",
"display" : "8. MARKETING AUTHORISATION NUMBER(S)"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>EU/1/23/1234/001</p></div>"
}
},
{
"id" : "61b98f40-58f4-4602-97ad-0212e3a5bda2",
"title" : "9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029846",
"display" : "9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>Date of first authorisation: 15 January 2020</p></div>"
}
},
{
"id" : "a6307678-ce1e-4bf2-b9a0-0b7a566887f7",
"title" : "10. DATE OF REVISION OF THE TEXT",
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000029847",
"display" : "10. DATE OF REVISION OF THE TEXT"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" lang=\"en\"><p>October 2023</p></div>"
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/Organization/org-epi-type3-example-pharma",
"resource" : {
"resourceType" : "Organization",
"id" : "org-epi-type3-example-pharma",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_org-epi-type3-example-pharma\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization org-epi-type3-example-pharma</b></p><a name=\"org-epi-type3-example-pharma\"> </a><a name=\"hcorg-epi-type3-example-pharma\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/LOC-100000000</p><p><b>active</b>: true</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 220000000034}\">Marketing authorisation holder</span></p><p><b>name</b>: WonderPharma Inc.</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Telecom</b></td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"tel:+420123456789\">+420 123 456 789</a>, <a href=\"mailto:info@wonderpharma.example.com\">info@wonderpharma.example.com</a>, <a href=\"https://www.wonderpharma.example.com\">https://www.wonderpharma.example.com</a></td><td>WonderPharma Inc., 123 Pharma Way, Prague 10, 102 37, Czech Republic</td></tr></table></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "LOC-100000000"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000034",
"display" : "Marketing authorisation holder"
}
]
}
],
"name" : "WonderPharma Inc.",
"contact" : [
{
"telecom" : [
{
"system" : "phone",
"value" : "+420 123 456 789"
},
{
"system" : "email",
"value" : "info@wonderpharma.example.com"
},
{
"system" : "url",
"value" : "https://www.wonderpharma.example.com"
}
],
"address" : {
"type" : "both",
"text" : "WonderPharma Inc., 123 Pharma Way, Prague 10, 102 37, Czech Republic",
"line" : [
"123 Pharma Way"
],
"city" : "Prague",
"district" : "Prague 10",
"state" : "Central Bohemia",
"postalCode" : "102 37",
"country" : "CZ"
}
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mpd-epi-type3-example-wonderdrug",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mpd-epi-type3-example-wonderdrug\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition mpd-epi-type3-example-wonderdrug</b></p><a name=\"mpd-epi-type3-example-wonderdrug\"> </a><a name=\"hcmpd-epi-type3-example-wonderdrug\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/WONDERDRUG-500MG</p><p><b>domain</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-domain Human}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Contact</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Organization-org-epi-type3-example-pharma.html\">Organization WonderPharma Inc.</a></td></tr></table><blockquote><p><b>name</b></p><p><b>productName</b>: WonderDrug 500 mg tablets</p><blockquote><p><b>part</b></p><p><b>part</b>: WonderDrug</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type InventedNamePart}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 500 mg</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type StrengthPart}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablets</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type DoseFormPart}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 EE}\">Estonia</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 et}\">Estonian</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "WONDERDRUG-500MG"
}
],
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"contact" : [
{
"contact" : {
🔗 "reference" : "Organization/org-epi-type3-example-pharma"
}
}
],
"name" : [
{
"productName" : "WonderDrug 500 mg tablets",
"part" : [
{
"part" : "WonderDrug",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "InventedNamePart",
"display" : "Invented name part"
}
]
}
},
{
"part" : "500 mg",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "StrengthPart",
"display" : "Strength part"
}
]
}
},
{
"part" : "tablets",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "DoseFormPart",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "EE",
"display" : "Estonia"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "et",
"display" : "Estonian"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol-100mg",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mpd-epi-type2-example-paracetamol-100mg",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mpd-epi-type2-example-paracetamol-100mg\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition mpd-epi-type2-example-paracetamol-100mg</b></p><a name=\"mpd-epi-type2-example-paracetamol-100mg\"> </a><a name=\"hcmpd-epi-type2-example-paracetamol-100mg\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/WONDERDRUG-100MG</p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><h3>Names</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ProductName</b></td></tr><tr><td style=\"display: none\">*</td><td>WonderDrug 100 mg tablets</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "WONDERDRUG-100MG"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"name" : [
{
"productName" : "WonderDrug 100 mg tablets"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol-200mg",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mpd-epi-type2-example-paracetamol-200mg",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mpd-epi-type2-example-paracetamol-200mg\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition mpd-epi-type2-example-paracetamol-200mg</b></p><a name=\"mpd-epi-type2-example-paracetamol-200mg\"> </a><a name=\"hcmpd-epi-type2-example-paracetamol-200mg\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/WONDERDRUG-200MG</p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><h3>Names</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>ProductName</b></td></tr><tr><td style=\"display: none\">*</td><td>WonderDrug 200 mg tablets</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "WONDERDRUG-200MG"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"name" : [
{
"productName" : "WonderDrug 200 mg tablets"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "mpd-epi-type2-example-paracetamol",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mpd-epi-type2-example-paracetamol\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition mpd-epi-type2-example-paracetamol</b></p><a name=\"mpd-epi-type2-example-paracetamol\"> </a><a name=\"hcmpd-epi-type2-example-paracetamol\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/WONDERDRUG-500MG</p><p><b>domain</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-domain Human}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000072084}\">Medicinal product subject to medical prescription</span></p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Contact</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Organization-org-epi-type2-example-acme.html\">Organization Acme Pharma Inc.</a></td></tr></table><blockquote><p><b>name</b></p><p><b>productName</b>: WonderDrug 500 mg tablets</p><blockquote><p><b>part</b></p><p><b>part</b>: WonderDrug</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type InventedNamePart}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 500 mg</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type StrengthPart}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablets</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-name-part-type DoseFormPart}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 EE}\">Estonia</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 et}\">Estonian</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "WONDERDRUG-500MG"
}
],
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"contact" : [
{
"contact" : {
🔗 "reference" : "Organization/org-epi-type2-example-acme"
}
}
],
"name" : [
{
"productName" : "WonderDrug 500 mg tablets",
"part" : [
{
"part" : "WonderDrug",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "InventedNamePart",
"display" : "Invented name part"
}
]
}
},
{
"part" : "500 mg",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "StrengthPart",
"display" : "Strength part"
}
]
}
},
{
"part" : "tablets",
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-name-part-type",
"code" : "DoseFormPart",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "EE",
"display" : "Estonia"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "et",
"display" : "Estonian"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/Organization/org-epi-type2-example-acme",
"resource" : {
"resourceType" : "Organization",
"id" : "org-epi-type2-example-acme",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_org-epi-type2-example-acme\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization org-epi-type2-example-acme</b></p><a name=\"org-epi-type2-example-acme\"> </a><a name=\"hcorg-epi-type2-example-acme\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/LOC-100000000</p><p><b>active</b>: true</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 220000000034}\">Marketing authorisation holder</span></p><p><b>name</b>: Acme Pharma Inc.</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>123 Pharma Way, 102 37 Prague 10, Czech Republic</td></tr></table></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/omswi",
"value" : "LOC-100000000"
}
],
"active" : true,
"type" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000034",
"display" : "Marketing authorisation holder"
}
]
}
],
"name" : "Acme Pharma Inc.",
"contact" : [
{
"address" : {
"text" : "123 Pharma Way, 102 37 Prague 10, Czech Republic",
"line" : [
"123 Pharma Way"
],
"city" : "Prague",
"postalCode" : "102 37",
"country" : "Czech Republic"
}
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/RegulatedAuthorization/ra-epi-type2-example-paracetamol",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "ra-epi-type2-example-paracetamol",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_ra-epi-type2-example-paracetamol\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization ra-epi-type2-example-paracetamol</b></p><a name=\"ra-epi-type2-example-paracetamol\"> </a><a name=\"hcra-epi-type2-example-paracetamol\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>http://ema.europa.eu/identifier</code>/MA-123456789</p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type2-example-paracetamol.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{urn:iso:std:iso:3166 EE}\">Estonia</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><p><b>holder</b>: <a href=\"Organization-org-epi-type2-example-acme.html\">Organization Acme Pharma Inc.</a></p></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/identifier",
"value" : "MA-123456789"
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "EE",
"display" : "Estonia"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"holder" : {
🔗 "reference" : "Organization/org-epi-type2-example-acme"
}
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/PackagedProductDefinition/ppd-epi-type2-example-paracetamol",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "ppd-epi-type2-example-paracetamol",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd-epi-type2-example-paracetamol\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition ppd-epi-type2-example-paracetamol</b></p><a name=\"ppd-epi-type2-example-paracetamol\"> </a><a name=\"hcppd-epi-type2-example-paracetamol\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/ppd-epi-type2-example-paracetamol</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-mpd-epi-type2-example-paracetamol.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073498}\">Box</span></p><p><b>quantity</b>: 1</p><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073496}\">Blister</span></p><blockquote><p><b>containedItem</b></p><h3>Items</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"ManufacturedItemDefinition-mid-epi-type2-example-paracetamol.html\">ManufacturedItemDefinition: identifier = http://example.org/identifier#mid-epi-type2-example-paracetamol; status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></td></tr></table><p><b>amount</b>: 30 Tablet</p></blockquote></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "ppd-epi-type2-example-paracetamol"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073496",
"display" : "Blister"
}
]
},
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/mid-epi-type2-example-paracetamol"
}
},
"amount" : {
"value" : 30,
"unit" : "Tablet",
"system" : "http://standardterms.edqm.eu"
}
}
]
}
]
}
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ManufacturedItemDefinition/mid-epi-type2-example-paracetamol",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "mid-epi-type2-example-paracetamol",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_mid-epi-type2-example-paracetamol\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition mid-epi-type2-example-paracetamol</b></p><a name=\"mid-epi-type2-example-paracetamol\"> </a><a name=\"hcmid-epi-type2-example-paracetamol\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ManufacturedItemDefinition-uv-epi.html\">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/mid-epi-type2-example-paracetamol</p><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073664}\">Tablet</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 200000002152}\">Tablet</span></p><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig shape}\">Shape</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073670}\">Round</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig color}\">Color</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073586}\">White</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig size}\">Size</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000000000}\">10 mm</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig score}\">Score</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000000000}\">Scored</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig imprint}\">Imprint</span></p><p><b>value</b>: </p><div><p>WD500</p>\n</div></blockquote></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "mid-epi-type2-example-paracetamol"
}
],
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000002152",
"display" : "Tablet"
}
]
},
"property" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "shape",
"display" : "Shape"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073670",
"display" : "Round"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "color",
"display" : "Color"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073586",
"display" : "White"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "size",
"display" : "Size"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000000000",
"display" : "10 mm"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "score",
"display" : "Score"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000000000",
"display" : "Scored"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "imprint",
"display" : "Imprint"
}
]
},
"valueMarkdown" : "WD500"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/AdministrableProductDefinition/apd-epi-type2-example-paracetamol",
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "apd-epi-type2-example-paracetamol",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_apd-epi-type2-example-paracetamol\"> </a><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition apd-epi-type2-example-paracetamol</b></p><a name=\"apd-epi-type2-example-paracetamol\"> </a><a name=\"hcapd-epi-type2-example-paracetamol\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-AdministrableProductDefinition-uv-epi.html\">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/apd-epi-type2-example-paracetamol</p><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-mpd-epi-type2-example-paracetamol.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073664}\">Tablet</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 200000002152}\">Tablet</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-mid-epi-type2-example-paracetamol.html\">ManufacturedItemDefinition: identifier = http://example.org/identifier#mid-epi-type2-example-paracetamol; status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig shape}\">Shape</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073670}\">Round</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig color}\">Color</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073586}\">White</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig flavor}\">Flavor</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000000000}\">None</span></p></blockquote><blockquote><p><b>property</b></p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig image}\">Image</span></p><p><b>value</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000000000}\">Tablet Image</span></p></blockquote><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000073619}\">Oral use</span></td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "apd-epi-type2-example-paracetamol"
}
],
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "200000002152",
"display" : "Tablet"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/mid-epi-type2-example-paracetamol"
}
],
"property" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "shape",
"display" : "Shape"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073670",
"display" : "Round"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "color",
"display" : "Color"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073586",
"display" : "White"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "flavor",
"display" : "Flavor"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000000000",
"display" : "None"
}
]
}
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "image",
"display" : "Image"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000000000",
"display" : "Tablet Image"
}
]
}
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000073619",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/Ingredient/ingredient-epi-type2-example-paracetamol-active",
"resource" : {
"resourceType" : "Ingredient",
"id" : "ingredient-epi-type2-example-paracetamol-active",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredient-epi-type2-example-paracetamol-active\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient ingredient-epi-type2-example-paracetamol-active</b></p><a name=\"ingredient-epi-type2-example-paracetamol-active\"> </a><a name=\"hcingredient-epi-type2-example-paracetamol-active\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/ingredient-epi-type2-example-paracetamol-active</p><p><b>status</b>: Active</p><p><b>for</b>: <a href=\"ManufacturedItemDefinition-mid-epi-type2-example-paracetamol.html\">ManufacturedItemDefinition: identifier = http://example.org/identifier#mid-epi-type2-example-paracetamol; status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000072072}\">Active</span></p><p><b>function</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000136065}\">API</span></p><p><b>group</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000136179}\">Chemical</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/smswi 100000000000}\">Paracetamol</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Presentation[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>500 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg = 'mg')</span>/1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: EDQM Standard Terms code10219000 = 'Tablet')</span></td></tr></table></blockquote></div>"
},
"identifier" : {
"system" : "http://example.org/identifier",
"value" : "ingredient-epi-type2-example-paracetamol-active"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "ManufacturedItemDefinition/mid-epi-type2-example-paracetamol"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000072072",
"display" : "Active"
}
]
},
"function" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000136065",
"display" : "API"
}
]
}
],
"group" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/rmswi",
"code" : "100000136179",
"display" : "Chemical"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/smswi",
"code" : "100000000000",
"display" : "Paracetamol"
}
]
}
},
"strength" : [
{
"presentationRatio" : {
"numerator" : {
"value" : 500,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"denominator" : {
"value" : 1,
"unit" : "tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "10219000"
}
}
}
]
}
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicationKnowledge/medication-knowledge-epi-type3-example",
"resource" : {
"resourceType" : "MedicationKnowledge",
"id" : "medication-knowledge-epi-type3-example",
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationKnowledge_medication-knowledge-epi-type3-example\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationKnowledge medication-knowledge-epi-type3-example</b></p><a name=\"medication-knowledge-epi-type3-example\"> </a><a name=\"hcmedication-knowledge-epi-type3-example\"> </a><p><b>status</b>: Active</p><blockquote><p><b>indicationGuideline</b></p><h3>Indications</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 386661006}\">Fever</span></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 22253000}\">Pain</span></td></tr></table><blockquote><p><b>dosingGuideline</b></p><p><b>treatmentIntent</b>: <span title=\"Codes:{http://snomed.info/sct 384812002}\">Pain relief</span></p><blockquote><p><b>dosage</b></p><p><b>type</b>: <span title=\"Codes:\">Initial Treatment (Week 1)</span></p><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: Take 1 tablet twice daily for the first week</p><p><b>timing</b>: 2 per 1 day</p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/dose-rate-type ordered}\">Ordered</span></td><td>1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: EDQM Standard Terms code10219000 = 'Tablet')</span></td></tr></table></blockquote></blockquote><blockquote><p><b>dosage</b></p><p><b>type</b>: <span title=\"Codes:\">Maintenance Treatment (Weeks 2-4)</span></p><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 2</p><p><b>text</b>: Take 1 tablet once daily for three more weeks</p><p><b>timing</b>: Once per 1 day</p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://terminology.hl7.org/CodeSystem/dose-rate-type ordered}\">Ordered</span></td><td>1 tablet<span style=\"background: LightGoldenRodYellow\"> (Details: EDQM Standard Terms code10219000 = 'Tablet')</span></td></tr></table></blockquote></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"indicationGuideline" : [
{
"indication" : [
{
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "386661006",
"display" : "Fever"
}
]
}
},
{
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "22253000",
"display" : "Pain"
}
]
}
}
],
"dosingGuideline" : [
{
"treatmentIntent" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "384812002",
"display" : "To relieve pain"
}
],
"text" : "Pain relief"
},
"dosage" : [
{
"type" : {
"text" : "Initial Treatment (Week 1)"
},
"dosage" : [
{
"sequence" : 1,
"text" : "Take 1 tablet twice daily for the first week",
"timing" : {
"repeat" : {
"boundsDuration" : {
"value" : 7,
"unit" : "days",
"system" : "http://unitsofmeasure.org",
"code" : "d"
},
"frequency" : 2,
"period" : 1,
"periodUnit" : "d"
}
},
"doseAndRate" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}
]
},
"doseQuantity" : {
"value" : 1,
"unit" : "tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "10219000"
}
}
]
}
]
},
{
"type" : {
"text" : "Maintenance Treatment (Weeks 2-4)"
},
"dosage" : [
{
"sequence" : 2,
"text" : "Take 1 tablet once daily for three more weeks",
"timing" : {
"repeat" : {
"boundsDuration" : {
"value" : 21,
"unit" : "days",
"system" : "http://unitsofmeasure.org",
"code" : "d"
},
"frequency" : 1,
"period" : 1,
"periodUnit" : "d"
}
},
"doseAndRate" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}
]
},
"doseQuantity" : {
"value" : 1,
"unit" : "tablet",
"system" : "http://standardterms.edqm.eu",
"code" : "10219000"
}
}
]
}
]
}
]
}
]
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-indication-1",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-indication-1",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-indication-1\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-indication-1</b></p><a name=\"cud-indication-1\"> </a><a name=\"hccud-indication-1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-indication-uv-epi.html\">ClinicalUseDefinition Indication (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-indication-1</p><p><b>type</b>: Indication</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig indication}\">Indication</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 386661006}\">Fever</span></td></tr></table></blockquote><p><b>population</b>: Adults</p></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-indication-1"
}
],
"type" : "indication",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "indication",
"display" : "Indication"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"indication" : {
"diseaseSymptomProcedure" : {
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "386661006",
"display" : "Fever"
}
]
}
}
},
"population" : [
{
"display" : "Adults"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-indication-2",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-indication-2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-indication-2\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-indication-2</b></p><a name=\"cud-indication-2\"> </a><a name=\"hccud-indication-2\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-indication-uv-epi.html\">ClinicalUseDefinition Indication (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-indication-2</p><p><b>type</b>: Indication</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig indication}\">Indication</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 22253000}\">Pain</span></td></tr></table></blockquote><p><b>population</b>: Adults</p></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-indication-2"
}
],
"type" : "indication",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "indication",
"display" : "Indication"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"indication" : {
"diseaseSymptomProcedure" : {
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "22253000",
"display" : "Pain"
}
]
}
}
},
"population" : [
{
"display" : "Adults"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-contraindication-1",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-contraindication-1",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-contraindication-1\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-contraindication-1</b></p><a name=\"cud-contraindication-1\"> </a><a name=\"hccud-contraindication-1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html\">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-contraindication-1</p><p><b>type</b>: Contraindication</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig contraindication}\">Contraindication</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>contraindication</b></p><h3>DiseaseSymptomProcedures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 197270009}\">Acute hepatic failure</span></td></tr></table></blockquote><p><b>population</b>: Adults</p></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-contraindication-1"
}
],
"type" : "contraindication",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "contraindication",
"display" : "Contraindication"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"contraindication" : {
"diseaseSymptomProcedure" : {
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "197270009",
"display" : "Acute hepatic failure"
}
]
}
}
},
"population" : [
{
"display" : "Adults"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-contraindication-2",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-contraindication-2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-contraindication-2\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-contraindication-2</b></p><a name=\"cud-contraindication-2\"> </a><a name=\"hccud-contraindication-2\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.html\">ClinicalUseDefinition Contraindication (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-contraindication-2</p><p><b>type</b>: Contraindication</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig contraindication}\">Contraindication</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>contraindication</b></p><blockquote><p><b>otherTherapy</b></p><p><b>relationshipType</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/benefit-and-risk-relationship contraindicated-only-with}\">Only contraindicated with</span></p><h3>Treatments</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 763158003}\">Medicinal product (product)</span></td></tr></table></blockquote></blockquote><p><b>population</b>: Adults</p></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-contraindication-2"
}
],
"type" : "contraindication",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "contraindication",
"display" : "Contraindication"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"contraindication" : {
"otherTherapy" : [
{
"relationshipType" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/benefit-and-risk-relationship",
"code" : "contraindicated-only-with",
"display" : "Only contraindicated with"
}
]
},
"treatment" : {
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "763158003",
"display" : "Medicinal product (product)"
}
]
}
}
}
]
},
"population" : [
{
"display" : "Adults"
}
]
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-interaction-1",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-interaction-1",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-interaction-1\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-interaction-1</b></p><a name=\"cud-interaction-1\"> </a><a name=\"hccud-interaction-1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html\">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-interaction-1</p><p><b>type</b>: Interaction</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig interaction}\">Interaction</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 372756006}\">Warfarin</span></td></tr></table><h3>Effects</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 404684003}\">Clinical finding (finding)</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-interaction-1"
}
],
"type" : "interaction",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "interaction",
"display" : "Interaction"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"interaction" : {
"interactant" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "372756006",
"display" : "Warfarin"
}
]
}
}
],
"effect" : {
"concept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "404684003",
"display" : "Clinical finding (finding)"
}
]
}
}
}
}
},
{
"fullUrl" : "http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/cud-interaction-2",
"resource" : {
"resourceType" : "ClinicalUseDefinition",
"id" : "cud-interaction-2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ClinicalUseDefinition_cud-interaction-2\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ClinicalUseDefinition cud-interaction-2</b></p><a name=\"cud-interaction-2\"> </a><a name=\"hccud-interaction-2\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html\">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>http://example.org/identifier</code>/cud-interaction-2</p><p><b>type</b>: Interaction</p><p><b>category</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig interaction}\">Interaction</span></p><p><b>subject</b>: <a href=\"Bundle-bundle-epi-type3-example-wonderdrug.html#http-//hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug\">MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active</a></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">Active</span></p><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 11289}\">Warfarin</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://example.org/identifier",
"value" : "cud-interaction-2"
}
],
"type" : "interaction",
"category" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-ig",
"code" : "interaction",
"display" : "Interaction"
}
]
}
],
"subject" : [
{
🔗 "reference" : "http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug"
}
],
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}
]
},
"interaction" : {
"interactant" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "11289",
"display" : "Warfarin"
}
]
}
}
]
}
}
}
]
}
IG © 2022+ HL7 International / Biomedical Research and Regulation.
Package hl7.fhir.uv.emedicinal-product-info#1.1.0 based on FHIR 5.0.0.
Generated
2026-04-03
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change